Alzheimer's & dementia : the journal of the Alzheimer's Association

Changing immune signals in support cells improves sleep and daily rhythms in female mice with Alzheimer's-related changes

Updated

Abstract

Only females showed midlife reductions in light-phase sleep and increased rhythm fragmentation from 2 to 19 months.

  • Sleep and circadian disturbances were observed in female mice with Alzheimer's-like features, while male mice did not exhibit the same changes.
  • Increased rhythm fragmentation and reduced rhythm stability were linked to selective reversal learning deficits in female mice.
  • Treatment with MW151 resulted in increased light-phase sleep and decreased levels of a specific inflammatory marker (TNF-α) in the cortex of aged female mice.
  • The effects of MW151 on sleep were independent of changes in amyloid beta accumulation.
  • Findings suggest that neuroinflammatory signaling may be a modifiable factor influencing sleep disturbances associated with Alzheimer's disease.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

LJVE is an inventor on patents covering MW151 and a scientific founder of ImmunoChem Therapeutics, LLC, a start‐up formed to commercialize MW151. BFO is a co‐founder and co‐owner of Signal Solutions LLC, which makes the PiezoSleep technology used here. The other authors declare no competing financial interests or conflicts of interest related to this manuscript. Author disclosures are available in the Supporting Information.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free